Search This Blog

Tuesday, October 29, 2019

NeoGenomics EPS beats by $0.01, beats on revenue

NeoGenomics (NASDAQ:NEO): Q3 Non-GAAP EPS of $0.07 beats by $0.01; GAAP EPS of $0.02 in-line.
Revenue of $104.67M (+51.5% Y/Y) beats by $5.29M.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.